menu search

CELL / PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates

PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates
PhenomeX Inc. (CELL) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.32 per share a year ago. Read More
Posted: May 11 2023, 19:02
Author Name: Zacks Investment Research
Views: 082137

CELL News  

PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates

By Zacks Investment Research
May 11, 2023

PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates

PhenomeX Inc. (CELL) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss o more_horizontal

PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023

By PRNewsWire
April 27, 2023

PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023

EMERYVILLE, Calif. , April 27, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Compan more_horizontal


Search within

Pages Search Results: